Drugs / 177Lu-TATE-RGD
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT06632873 | Sep 2024 → Jan 2025 overdue | — | Peking Union Medical College Hospital | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 177Lu-TATE-RGD | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06632873 ↗ |
| Route | Intravenous | “accepted intravenous injection of 177Lu-TATE-RGD” NCT06632873 ↗ |